Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Oxidative Medicine and Cellular Longevity|March 27, 2018
Modulation of Adipocyte Differentiation and Proadipogenic Gene Expression by Sulforaphane, Genistein, and Docosahexaenoic Acid as a First Step to Counteract ObesityVeronica Valli, Katharina Heilmann, Francesca Danesi, et al.
Frontiers in Veterinary Science|April 27, 2026
Cloning, structural and functional characterization of the ABCB1 transporter of the Eurasian bullfinch (<i>Pyrrhula pyrrhula</i>)Katharina Heilmann, Luise Charlotte Kempf, Lisa Siegl, et al.
Chemical Communications (Cambridge, England)|May 30, 2013
A generic strategy for pharmacological caging of growth factors for tissue engineeringMaria Karlsson, Philipp S Lienemann, Natallia Sprossmann, et al.
The EMBO Journal|April 19, 2012
Distinct requirement for an intact dimer interface in wild-type, V600E and kinase-dead B-Raf signallingMichael Röring, Ricarda Herr, Gina J Fiala, et al.
The International Journal of Neuropsychopharmacology|February 13, 2013
Nicotine enhances antisaccade performance in schizophrenia patients and healthy controlsNadine Petrovsky, Ulrich Ettinger, Boris B Quednow, et al.
International Psychogeriatrics|November 29, 2016
Treatment preferences for depression in the elderlyClaudia Luck-Sikorski, Janine Stein, Katharina Heilmann, et al.
Journal of Affective Disorders|January 18, 2016
The assessment of met and unmet care needs in the oldest old with and without depression using the Camberwell Assessment of Need for the Elderly (CANE): Results of the AgeMooDe studyJanine Stein, Alexander Pabst, Siegfried Weyerer, et al.
The EMBO Journal|December 15, 2015
Activation loop phosphorylation regulates B-Raf in vivo and transformation by B-Raf mutantsMartin Köhler, Michael Röring, Björn Schorch, et al.
Oncotarget|April 19, 2014
Sulforaphane counteracts aggressiveness of pancreatic cancer driven by dysregulated Cx43-mediated gap junctional intercellular communicationTobias Forster, Vanessa Rausch, Yiyao Zhang, et al.
Oncoimmunology|March 28, 2017
Suppression of indoleamine-2,3-dioxygenase 1 expression by promoter hypermethylation in ER-positive breast cancerDyah L Dewi, Soumya R Mohapatra, Saioa Blanco Cabañes, et al.
Pageof 1